News — Living longer is not enough—living better is the real goal. Healthspan research is gaining momentum, with major players in biotech and venture capital exploring ways to extend the period of life spent in good health. From cutting-edge therapies to wearable technology and AI-driven diagnostics, the industry is evolving rapidly. But with long development timelines and regulatory uncertainties, how can investors navigate this emerging field? We break down the key factors that will determine whether healthspan science is the next big bet or a risky gamble.
Speakers Include:
H.R.H. Prince Khaled Bin Alwaleed Bin Talal Al Saud – Founder & CEO, KBW Ventures, Saudi Arabia
Dr. Grey Bailey – Executive Chairman & Co-Founder, Juvenescence, UK
Jim Scopa - Director, Hevolution U.S. LLC, USA
Dr. Werner Lanthaler – CEO, Wlanholding GmbH & Age X Partners, Austria
Dr. Helmut M. Schuehsler – Chairman & CEO, TVM Capital Healthcare, UAE
RSS